Implante de válvula aórtica percutánea con técnica de sedación consciente

Background: Transfemoral transcatheter aortic valve implantation (TAVI) is the standard of treatment for patients with symptomatic severe aortic stenosis (AE) and intermediate or high surgical risk. The use of conscious sedation (CS) could reduce complications and allow an early discharge of these...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hameau D.,René, Olmos C.,Alfonso, Rodríguez B.,Claudia, Meriño S.,Gustavo, Pérez P.,Osvaldo
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2021
Materias:	Aortic Valve Stenosis Conscious Sedation Transcatheter Aortic Valve Replacement
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000400520
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872021000400520
record_format	dspace
spelling	oai:scielo:S0034-988720210004005202021-08-26Implante de válvula aórtica percutánea con técnica de sedación conscienteHameau D.,RenéOlmos C.,AlfonsoRodríguez B.,ClaudiaMeriño S.,GustavoPérez P.,Osvaldo Aortic Valve Stenosis Conscious Sedation Transcatheter Aortic Valve Replacement Background: Transfemoral transcatheter aortic valve implantation (TAVI) is the standard of treatment for patients with symptomatic severe aortic stenosis (AE) and intermediate or high surgical risk. The use of conscious sedation (CS) could reduce complications and allow an early discharge of these patients. Aim: To report our experience with TAVI under conscious sedation. Material and Methods: Review of medical records of 15 patients aged 79 ± 6 years (53% women) undergoing a transfemoral TAVI implant under conscious sedation. Results: The indications for the procedure were severe AE in 13 patients and biological prosthetic dysfunction in two. The mean Thoracic Surgeons predicted risk of mortality score was 7.3. The valves used were Edwards Sapien 3 in three patients, Medtronic Evolut in five, Boston Acurate Neo in four and Meril Myval in three. A successful implant was achieved in all cases and there were no hospital mortality or pacemaker requirements. One patient had a stroke, and one patient had a vascular access complication. Early discharge (< 72 h) was achieved in 80% of patients. Conclusions: TAVI under conscious sedation was a safe procedure and associated with a complication rate similar to previous reports, allowing for an early hospital discharge in most patients.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.149 n.4 20212021-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000400520es10.4067/s0034-98872021000400520
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Aortic Valve Stenosis Conscious Sedation Transcatheter Aortic Valve Replacement
spellingShingle	Aortic Valve Stenosis Conscious Sedation Transcatheter Aortic Valve Replacement Hameau D.,René Olmos C.,Alfonso Rodríguez B.,Claudia Meriño S.,Gustavo Pérez P.,Osvaldo Implante de válvula aórtica percutánea con técnica de sedación consciente
description	Background: Transfemoral transcatheter aortic valve implantation (TAVI) is the standard of treatment for patients with symptomatic severe aortic stenosis (AE) and intermediate or high surgical risk. The use of conscious sedation (CS) could reduce complications and allow an early discharge of these patients. Aim: To report our experience with TAVI under conscious sedation. Material and Methods: Review of medical records of 15 patients aged 79 ± 6 years (53% women) undergoing a transfemoral TAVI implant under conscious sedation. Results: The indications for the procedure were severe AE in 13 patients and biological prosthetic dysfunction in two. The mean Thoracic Surgeons predicted risk of mortality score was 7.3. The valves used were Edwards Sapien 3 in three patients, Medtronic Evolut in five, Boston Acurate Neo in four and Meril Myval in three. A successful implant was achieved in all cases and there were no hospital mortality or pacemaker requirements. One patient had a stroke, and one patient had a vascular access complication. Early discharge (< 72 h) was achieved in 80% of patients. Conclusions: TAVI under conscious sedation was a safe procedure and associated with a complication rate similar to previous reports, allowing for an early hospital discharge in most patients.
author	Hameau D.,René Olmos C.,Alfonso Rodríguez B.,Claudia Meriño S.,Gustavo Pérez P.,Osvaldo
author_facet	Hameau D.,René Olmos C.,Alfonso Rodríguez B.,Claudia Meriño S.,Gustavo Pérez P.,Osvaldo
author_sort	Hameau D.,René
title	Implante de válvula aórtica percutánea con técnica de sedación consciente
title_short	Implante de válvula aórtica percutánea con técnica de sedación consciente
title_full	Implante de válvula aórtica percutánea con técnica de sedación consciente
title_fullStr	Implante de válvula aórtica percutánea con técnica de sedación consciente
title_full_unstemmed	Implante de válvula aórtica percutánea con técnica de sedación consciente
title_sort	implante de válvula aórtica percutánea con técnica de sedación consciente
publisher	Sociedad Médica de Santiago
publishDate	2021
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000400520
work_keys_str_mv	AT hameaudrene implantedevalvulaaorticapercutaneacontecnicadesedacionconsciente AT olmoscalfonso implantedevalvulaaorticapercutaneacontecnicadesedacionconsciente AT rodriguezbclaudia implantedevalvulaaorticapercutaneacontecnicadesedacionconsciente AT merinosgustavo implantedevalvulaaorticapercutaneacontecnicadesedacionconsciente AT perezposvaldo implantedevalvulaaorticapercutaneacontecnicadesedacionconsciente
_version_	1718437195891605504

Implante de válvula aórtica percutánea con técnica de sedación consciente

Ejemplares similares